SCHEMBL12338273

SCHEMBL12338273

c1ccc(-n2c3ccccc3c3cc(-c4c5ccccc5c(-c5ccc(-c6cccc7ccccc67)cc5)c5c4ccc4ccccc45)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ PTGES O14684 1/20 0.35
▸ KMT2A Q03164 1/20 0.34
▸ MCL1 Q07820 1/20 0.33
▸ ACMSD Q8TDX5 1/20 0.33
▸ TLR4 O00206 1/20 0.33
▸ PTGER4 P35408 1/20 0.33
▸ CA12 O43570 2/20 0.33
▸ CA1 P00915 2/20 0.33
▸ CA2 P00918 2/20 0.33
▸ CA9 Q16790 2/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ MAPK14 Q16539 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ NTSR1 P30989 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12338304 1.00 KDM4E (0.41) KDM4EATML3MBTL1PTGESKMT2A
SCHEMBL12338251 0.93 KDM4E (0.43) KDM4EATML3MBTL1PTGESKMT2A
SCHEMBL26813184 0.92 L3MBTL1 (0.46) KDM4EATML3MBTL1PTGESKMT2A
SCHEMBL12338211 0.92 L3MBTL1 (0.49) KDM4EATML3MBTL1PTGESKMT2A
SCHEMBL17917508 0.92 KDM4E (0.49) KDM4EATML3MBTL1KMT2AMCL1
SCHEMBL26813192 0.91 KDM4E (0.41) KDM4EATML3MBTL1PTGESKMT2A
SCHEMBL17718061 0.91 L3MBTL1 (0.43) KDM4EATML3MBTL1PTGESKMT2A
SCHEMBL13669238 0.91 KDM4E (0.45) KDM4EATML3MBTL1KMT2AMCL1
SCHEMBL11910811 0.91 KDM4E (0.45) KDM4EATML3MBTL1KMT2AMCL1
SCHEMBL19103077 0.91 L3MBTL1 (0.45) KDM4EATML3MBTL1PTGESKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268459-B2 Benzanthracene compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2012-09-18 — — US disclosed
US-8268459-B2 Benzanthracene compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2012-09-18 — — US disclosed
US-20100301313-A1 BENZANTHRACENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. 2010-12-02 — — US disclosed
US-20100301313-A1 BENZANTHRACENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. 2010-12-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100301313-A1 BENZANTHRACENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME AHR, TRPA1, LEF1 KDM4E 2280/4885ATM 1893/4885L3MBTL1 3059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback